More information: Alina Renz et al, Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses, Communications Biology (2025). DOI: 10.1038 ...

The expensive medication does little to prevent hospitalisation or death for people who are vaccinated against the virus, a ...

Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that its broad-spectrum protease inhibitor CDI-988 will be featured in an oral presentation at the 2025 Military Health System Research Symposium (MHSRS ...

This method accelerates the time-consuming identification and development of antiviral agents that could be crucial in the event of future pandemics. Detecting potential targets for antiviral ...

Renz A. et al, Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses, Communications Biology, 23 Mai 2025, https: ...

Global Oral Antiviral Market is valued approximately USD 36.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 2.10% over the forecast period 2024-2032. Read the ...

About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases ...

"All influenza antiviral drugs exert a selective pressure on viruses, which can result in the emergence of drug-resistant variants," Monto and team explained. Still, ...

Therefore, fast-acting antiviral drugs with broad activity against multiple respiratory coronaviruses and the ability to be rapidly distributed as oral treatments are urgently needed. By creating a ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...